Detalles de la búsqueda
1.
Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).
Clin Colorectal Cancer
; 19(2): 109-115, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32089455
2.
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
Breast
; 53: 18-22, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32540553
3.
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.
Mol Cancer Ther
; 18(4): 845-855, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30824612
4.
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
Clin Lung Cancer
; 16(4): 262-73, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25582493
Resultados
1 -
4
de 4
1
Próxima >
>>